2025-09-11T12:23:16-05:00 2024-12-31 273858252 DEAN DORTON ALLEN FORD PLLC 810 WRIGHTS SUMMIT PARKWAY SUITE 300 FORT WRIGHT KY 41011 990 2024-01-01 260269131 THE CURE STARTS NOW INC CURE 5137724888 10280 CHESTER ROAD CINCINNATI OH 45215 BROOKE DESSERICH EXECUTIVE DIRECTOR/CEO 5137724888 2025-09-05 1 0 BRYAN PAUTSCH P00034913 8593313300 2025-09-05 2024 2025-03-06 01:10:19Z BROOKE DESSERICH 10280 CHESTER ROAD CINCINNATI OH 45215 5749364 0 X WWW.THECURESTARTSNOW.ORG X 2007 OH TO EDUCATE, AID, AND FUND CURES FOR CANCER, STARTING FIRST WITH PEDIATRIC BRAIN CANCER 7 4 18 1100 0 0 3674963 4252213 0 0 0 16804 1405730 1098363 5080693 5367380 2271664 1990415 0 0 1262140 1382173 0 0 683457 1226503 1008455 4760307 4381043 320386 986337 4130907 4248120 1703931 834807 2426976 3413313 TO EDUCATE, AID, AND FUND CURES FOR CANCER, STARTING FIRST WITH PEDIATRIC BRAIN CANCER 0 0 2011460 1990415 IN ITS EFFORTS TO FOCUS ON THOSE CANCERS THAT PRESENT THE GREATEST OPPORTUNITIES FOR AN ENCOMPASSING CANCER CURE, THE FOUNDATION ANNUALLY AWARDS RESEARCH GRANTS TO INSTITUTIONS AND MEDICAL PROFESSIONALS. TYPICALLY, GRANTS AWARDED HAVE A FOCUS ON PEDIATRIC BRAIN CANCERS, AS THIS WAS THE ORIGIN OF THE FOUNDATION'S PHILOSOPHY. GRANT APPLICATIONS WILL BE JUDGED ON A PEER-REVIEWED BASIS WITH THE FOUNDATION'S MEDICAL ADVISORY COUNCIL, WHICH IS COMPRISED OF TOP ONCOLOGISTS AND RESEARCHERS FROM AROUND THE WORLD, AS WELL AS PARENT ADVOCATES. GRANTS ARE JUDGED BASED ON MULTIPLE CRITERIA INCLUDING SCIENTIFIC MERIT, DISEASE IMPACT, INNOVATION, FEASIBILITY, AND EXPERTISE OF THE INVESTIGATOR. 1470112 FAMILY SUPPORT AND AWARENESS FUNDS PROVIDE EMOTIONAL SUPPORT, MECHANISMS TO HONOR THEIR CHILD'S LEGACY AND OTHER ASSISTANCE FOR FAMILIES BATTLING PEDIATRIC CANCER. THIS INCLUDES INFORMATION WEBSITES, TRIAL DISCOVERY TOOLS, PATIENT ASSISTANCE AND PROGRAMS TO FEATURE PATIENTS WITH THE INTENTION OF BUILING LOCAL SUPPORT AND AWARENESS. 112979 THE DIPG/DMG SYMPOSIUM, ORIGINALLY HELD IN CINCINNATI IN 2011, IS A BIENNIAL CONFERENCE THAT FEATURES CANCER EXPERTS FROM AROUND THE WORLDIN COLLABORATION WITH FAMILIES AND FOUNDATIONS SUPPORTING THEIR WORK.ATTENDED BY FOUNDATIONS AND INSTITUTIONS WORLDWIDE. THE DIPG/DMGCOLLABORATIVE SYMPOSIUM QUICKLY BECAME A DYNAMIC COOPERATIVE, EXPLORINGREVOLUTIONARY DIPG AND DMG RESEARCH, CLINICAL PROTOCOLS, AND UNIVERSALAPPLICATIONS OF DIPG RESEARCH IN THE SEARCH FOR A CURE FOR ALL FORMS OFCANCER. 3594551 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 3 0 18 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 7 4 1 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AR CA CO CT FL GA IA IL IN KS KY LA MA MD MI MN MS NC NE NH NJ NY OH OR PA RI SC TN TX UT VA WA WI HI MO NV X X BROOKE DESSERICH 5137724888 10280 CHESTER RD CINCINNATI OH 45215 KEITH DESSERICH CHAIRMAN 60.00 X X 62145 0 22803 DOUG DESSERICH DIRECTOR/TREASURER 1.00 X X 0 0 0 GAVIN BAUMGARDNER DIRECTOR 5.00 X X 0 0 0 TAMARA EKIS DIRECTOR 1.00 X X 0 0 0 DAN LEE DIRECTOR 1.00 X X 0 0 0 ALYSSA HAWRANKO DIRECTOR 1.00 X X 0 0 0 TERRY REGAN DIRECTOR 1.00 X X 0 0 0 BROOKE DESSERICH EXECUTIVE DIRECTOR/CEO 60.00 X 91252 0 16066 MIKE WEINER CIO 60.00 X 118170 0 32652 271567 0 71521 1 0 1 0 0 1342012 2910201 4252213 16804 16804 1480347 1342012 381984 1098363 1098363 5367380 0 0 1115167 1218250 1218250 772165 772165 153397 100957 5982 46458 839956 552810 32753 254393 388820 268805 13667 106348 6414 4434 226 1754 47456 32808 1668 12980 40340 27888 1418 11034 173061 171557 1504 74678 51801 2605 20272 71900 49815 2515 19570 200786 138810 7058 54918 14304 11416 2888 21847 21847 32577 11301 9678 11598 PROGRAM SUPPLIES 177599 107854 69745 WEBSITE 102900 71138 3618 28144 MISCELLANEOUS 41851 41851 ADVOCACY 2742 2742 4381043 3594551 103035 683457 3467967 3728984 1374 1500 236410 276727 271875 248599 45123 23276 2047 1872 29940 30214 348046 185547 4130907 4248120 100794 132277 1227428 470400 27663 56583 348046 175547 1703931 834807 X 1923616 2924505 503360 488808 2426976 3413313 4130907 4248120 986337 0 X 0 1 X 1 0 X 2129478 3378419 4315043 3674963 4252213 17750116 2129478 3378419 4315043 3674963 4252213 17750116 570097 17180019 16804 16804 1221308 873279 916587 1405730 1098363 5515267 23282187 45000 0.73790 0.68000 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: NET FUNDRAISING INCOME - 2020 AMOUNT: $ 1,221,308. 2021 AMOUNT: $ 872,574. 2022 AMOUNT: $ 912,422. 2023 AMOUNT: $ 1,402,855. 2024 AMOUNT: $ 1,098,363. OTHER INCOME - 2021 AMOUNT: $ 705. 2022 AMOUNT: $ 4,165. 2023 AMOUNT: $ 2,875. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 0 0 0 0 0 1 2749 0 0 2749 0 PART II-B, LINE 1: COST FOR TRAVEL TO MEET WITH CONGRESSIONAL COMMITTEE, AND LOBBY ACTIONS CONNECTED TO THE PROMISING PATHWAYS ACT GENERALLY REFERRED TO AS SENATE BILL S.1906 AND HOUSE BILL H.R.4408. 145375 122099 23276 32896 32896 0 93604 93604 0 23276 LONG TERM LEASE LIABILITY 175547 175547 X 5974195 224831 381984 606815 5367380 0 5367380 4987858 224831 381984 606815 4381043 0 4381043 PART X, LINE 2: THE CURE STARTS NOW, INC. IS A OHIO NONPROFIT ORGANIZATION AS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND ARE EXEMPT FROM FEDERAL AND STATE INCOME TAXES ON RELATED INCOME PURSUANT TO THE INTERNAL REVENUE CODE. THE ORGANIZATION HAS ADOPTED THE PROVISIONS OF THE ACCOUNTING PRONOUNCEMENT RELATED TO ACCOUNTING FOR UNCERTAINITY IN INCOME TAXES. THE ORGANIZATION RECOGNIZED NO INTEREST OR PENALTIES IN THE STATEMENTS OF ACTIVITIES FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. IF THE SITUATION AROSE IN WHICH THE ORGANIZATION WOULD HAVE INTEREST TO RECOGNIZE, IT WOULD BE RECOGNIZED IN OTHER EXPENSES. CURRENTLY, THE PRIOR THREE YEARS ARE OPEN UNDER FEDERAL AND STATE STATUTUES OF LIMITATIONS AND REMAIN SUBJECT TO REVIEW AND CHANGE. THE ORGANIZATION IS NOT CURRENTLY UNDER AUDIT NOR HAS THE ORGANIZATION BEEN CONTACTED BY THESE JURISDICTIONS. BASED ON THE EVALUATION OF THE ORGANIZATION'S TAX POSITIONS, MANAGEMENT BELIEVES ALL POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISION FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAS BEEN RECORDED FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 381,984. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 381,984. 1 MIDDLE EAST 0 0 PROGRAM SERVICES MEDICAL RESEARCH 40000 NORTH AMERICA 0 0 PROGRAM SERVICES MEDICAL RESEARCH 100000 EUROPE 0 0 PROGRAM SERVICES MEDICAL RESEARCH 165188 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES MEDICAL RESEARCH 466977 0 0 0 0 0 0 772165 0 772165 EAST ASIA AND THE PACIFIC MEDICAL RESEARCH 170400 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC MEDICAL RESEARCH 196577 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC MEDICAL RESEARCH 100000 WIRE TRANSFER 0 NORTH AMERICA MEDICAL RESEARCH 100000 WIRE TRANSFER 0 MIDDLE EAST MEDICAL RESEARCH 40000 WIRE TRANSFER 0 EUROPE MEDICAL RESEARCH 165188 WIRE TRANSFER 0 7 0 0 0 0 0 0 0 PART I, LINE 2: A PROGRESS REPORT MUST BE SUBMITTED BY THE INVESTIGATOR(S) ON ANNUAL INTERVALS AND AT THE END OF THE OF THE FUNDING PERIOD. FAILURE TO SUBMIT A PROGRESS REPORT WILL EXCLUDE THE INVESTIGATOR FROM ANY FUTURE FUNDING FROM THE FOUNDATION. BI-YEARLY RESEARCHERS MUST PRESENT IN-PERSON AT THE DIPG SYMPOSIUM. ONCE IN A LIFETIME GALA 681617 54236 627381 9548 115296 20294 24052 CT BLAST WALK 131980 64186 67794 602 6213 211 2008762 1223590 785172 71698 95895 29915 8471 2822359 1342012 1480347 81848 211191 50209 38736 381984 1098363 1 CINCINNATI CHILDREN'S HOSPITAL 3333 BURNET AVENUE ML 4900 CINCINNATI OH 45229 310833936 501(C)(3) 93250 0 DR BIPLAB DASGUPTA - EXPLORING NOVEL TARGETS IN DIPG CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 3333 BURNET AVENUE ML 4900 CINCINNATI OH 45229 310833936 501(C)(3) 200000 0 DR LU - "TARGETING DIPG WITH INNOVATIVE T-CELL IMMUNOTHERAPY" PEDIATRIC BRAIN TUMOR CONSORTIUM FOUNDATION 10280 CHESTER RD CINCINNATI OH 45215 208573849 501(C)(3) 25000 0 MEDICAL RESEARCH CHILDREN'S HOSPITAL OF PHILADELPHIA 3401 CIVIC CENTER BOULEVARD PHILADELPHIA PA 19104 231352166 501(C)(3) 100000 0 DR. JESSICA FOSTER - MEDICAL RESEARCH JOHNS HOPKINS HOSPITAL 1800 ORLEANS STREET BALTIMORE MD 21205 520595110 501(C)(3) 100000 0 DR. MICHAEL KOLDOBSKIY - MEDICAL RESEARCH UNC ESHELMAN SCHOOL OF PHARMACY 301 PHARMACY LANE CHAPEL HILL NC 27599 566001393 GOV 50000 0 DR. DAVID DREWRY - MEDICAL RESEARCH CHILDREN'S HEALTHCARE OF ATLANTA (EMORY UNIVERISTY) 1600 TULLIE CIRCLE ALTANTA GA 30329 580566256 GOV 100000 0 DR. ANNA KENNEY - MEDICAL RESEARCH CHILDREN'S NATIONAL MEDICAL CENTER (UNIVERSITY OF FLORIDA) 111 MICHIGAN AVENUE WASHINGTON DC 20010 596002052 GOV 300000 0 DR. GENE HWANG - MEDICAL RESEARCH UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO 7703 FLOYD CURL DRIVE SAN ANTONIO TX 78229 741586031 GOV 100000 0 DR. MANEET ROA - MEDICAL RESEARCH UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO 7703 FLOYD CURL DRIVE SAN ANTONIO TX 78229 741586031 GOV 50000 0 DR. LUIZ PENALVA - MEDICAL RESEARCH CHILDREN'S HOSPITAL LOS ANGELES 4650 WEST SUNSET BOULEVARD LOS ANGELES CA 90027 951690977 501(C)(3) 100000 0 DR. JESSICA TSAI - MEDICAL RESEARCH 11 PART I, LINE 2: GRANT FUNDS ARE MONITORED BY A MEDICAL ADVISORY COUNCIL. GRANT APPLICATIONS ARE REVIEWED BY THE MEDICAL ADVISORY COMMITTEE AND THEY PROVIDE THEIR SUGGESTIONS FOR FUNDING. THOSE SUGGESTIONS ARR ACCEPTED BY THE STRATEGIC COUNCIL COMPRISED OF CHAPTER REPRESENTATIVES. APPLICATIONS ARE THEN APPROVED BY THE BOARD OF DIRECTORS. X X X X 0 0 0 0 0 0 0 0 0 MIKE WEINER CIO 118170 0 0 0 0 0 5908 0 26744 0 150822 0 0 0 KEITH DESSERICH KEITH IS SOLE MEMBER OF TIOC, LLC 177304 RENTAL AGREEMENT - THIS TRANSACTION HAS BEEN APPROVED BY THE BOARD AND IS COMPARATIVE TO AVERAGE RENTAL COST OF THE AREA. AMOUNT INCLUDES UTILITIES, BUILDING MAINTENANCE, SERVICES, TAXES AND INSURANCE. 0 FORM 990, PART VI, SECTION A, LINE 2 GAVIN BAUMGARDNER, DOUGLAS DESSERICH, KEITH DESSERICH, AND BROOKE DESSERICH HAVE A FAMILY RELATIONSHIP FORM 990, PART VI, SECTION A, LINE 7B DECISIONS OF THE GOVERNING BODY ARE APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE EXECUTIVE DIRECTOR PREPARES THE FINANCIAL STATMENTS; THE CHAIRMAN OF THE BOARD AND THE TREASURER REVIEW THE FINANCIAL STATEMENTS DRAFTS FROM THE ACCOUNTING FIRM. THE ACCOUNTING FIRM PREPARES THE FORM 990 AND IT IS PRESENTED TO THE BOARD OF DIRECTORS AT THE FOLLOWING MEETING AND PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR THE CONFLICT OF INTEREST POLICY IS RE-SENT AND THE MEMBERS OF THE BOARD OF DIRECTORS RE-SIGN THE POLICY. ANY BOARD MEMBERS WITH A CONFLICT CANNOT DISCUSS OR VOTE ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 AT THE TIME OF COMPENSATION REVIEW, THE BOARD OF DIRECTORS REVIEW A COMPENSATION REPORT AND ENSURE THE COMPENSATION IS WITHIN LIMITS OF SIMILAR EXECUTIVE DIRECTORS IN THE GEOGRAPHY AND SIZE OF THE ORGANIZATION. THE EXECUTIVE DIRECTOR REVIEWS THE COMPENSATION REPORT AND ENSURES THE COMPENSATION IS WITHIN LIMITS OF SIMILAR KEY EMPLOYEES IN THE GEOGRAPHY AND SIZE OF THE ORGANIZATION. FORM 990, PART VI, SECTION C, LINE 19 AN ANNUAL REPORT, FINANCIAL STATEMENTS, AND OTHER STATISTICAL INFORMATION ARE ALL ON WEBSITE.